Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Страница 1 от 52 полученные результаты
Lipase inhibiting composition
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD
The present invention relates to lipase inhibiting compositions having reduced food dependency and decreased formation of free oil.
DESCRIPTION
Lipase inhibitors are well known in the art and include lipstatin and orlistat. The latter is also known as tetrahydrolipstatin or THL and is derived
Lipase inhibiting composition
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field
The present invention relates to lipase inhibiting compositions having reduced food dependency and decreased formation of free oil.
2. Description
Lipase inhibitors are well known in the art and include lipstatin and orlistat. The latter is also known as
Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
This invention relates to epigallocatechin dimers or trimers having lipase inhibitory activity, and foods and beverages that have those dimers or trimers incorporated therein. The invention also relates to epigallocatechin dimers or trimers having antioxidant action, and foods and
Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidant activity
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS-REFERENCE TO RELATED APPLICATION
This application is a U.S. National Stage Application of International Application No. PCT/JP2005/009666, filed May 26, 2005, and claims benefit of Japanese application No. 158462-2004 filed May 27, 2004.
TECHNICAL FIELD
This invention relates to
Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
The present invention relates to azolopyridin-2-one derivatives of the general formula I, to their pharmaceutically useful salts and to their use as medicinal substances.
Compounds of similar structure are known from EP 1275653. However, these are used as fungicides.
Compounds having an inhibitory
Lipase activity inhibitors containing high-molecular weight polyphenol fractions, tea extracts, and processes for producing the same
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
The present invention has been accomplished on the basis of the finding that high-molecular weight polyphenols (polymerized catechins) contained in oolong tea and other tea products exhibit various beneficial effects whereas they are less astringent and bitter than other tannins and
Lipase-colipase inhibitor
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
DESCRIPTION OF THE PRIOR ART
TECHNICAL FIELD
The present invention relates to a new group of therapeutically active organic compounds useful in particular as inhibitors of the lipase-colipase system for the prevention of obesity.
BACKGROUND OF THE INVENTION
Lipases is a group of enzymes taking part
Essentially nonabsorbable lipase inhibitor derivatives, pharmaceutical compositions and methods of use therefor
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
This invention relates to lipase inhibitors that have been rendered non-absorbable by linking such lipase inhibitors to a non-absorbable support.
BACKGROUND OF THE INVENTION
Lipase inhibitors such as esterastin (see U.S. Pat. No. 4,189,438), tetrahydroesterastin
Lipase inhibiting polymers
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Human obesity is a recognized health problem with approximately ninety-seven million people considered clinically overweight in the United States. The accumulation or maintenance of body fat bears a direct relationship to caloric intake. Therefore, one of the most common
Lipase inhibiting polymers
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Human obesity is a recognized health problem with approximately ninety-seven million people considered clinically overweight in the United States. The accumulation or maintenance of body fat bears a direct relationship to caloric intake. Therefore, one of the most common
Lipase inhibiting polymers
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Human obesity is a recognized health problem with approximately ninety-seven million people considered clinically overweight in the United States. The accumulation or maintenance of body fat bears a direct relationship to caloric intake. Therefore, one of the most common
Lipase inhibiting polymers
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Human obesity is a recognized health problem with approximately ninety-seven million people considered clinically overweight in the United States. The accumulation or maintenance of body fat bears a direct relationship to caloric intake. Therefore, one of the most common
Lipase inhibiting polymers
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Human obesity is a recognized health problem with approximately ninety-seven million people considered clinically overweight in the United States. The accumulation or maintenance of body fat bears a direct relationship to caloric intake. Therefore, one of the most common
Compounds for treatment of lipase-mediated diseases
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD OF THE INVENTION
The present invention relates to diseases and conditions mediated by genes of the lipase family. In particular, the invention relates to novel benzoquinone-derived compounds that affect the activity of lipase gene family enzymes.
BACKGROUND OF THE INVENTION
In many
Pharmaceutical composition comprising lipase inhibitor and lipophilic oil absorbent and oral formulation prepared therefrom
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a 35 USC .sctn.371 National Phase Entry Application from PCT/KR2007/001938, filed Apr. 20, 2007, and designating the United States. This application claims priority under 35 U.S.C. .sctn.119 based on Korean Patent Application No.
Самая полная база данных о лекарственных травах, подтвержденная наукой
- Работает на 55 языках
- Травяные лекарства, подтвержденные наукой
- Распознавание трав по изображению
- Интерактивная карта GPS - отметьте травы на месте (скоро)
- Прочтите научные публикации, связанные с вашим поиском
- Ищите лекарственные травы по их действию
- Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов
Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.
